Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Collegium Pharmaceutical, Inc. - Common Stock
(NQ:
COLL
)
39.16
+0.36 (+0.93%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 2, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Collegium Pharmaceutical, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
Collegium Announces Fourth Quarter and Full Year 2022 Preliminary Financial Results
February 06, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Collegium Provides 2023 Financial Guidance
January 04, 2023
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Appeals Court Affirms Validity of Collegium’s Belbuca® Patents
December 22, 2022
Ruling bars ANDA filer Alvogen from entering market until 2032 patent expiry
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Collegium to Participate in Piper Sandler 34th Annual Healthcare Conference
November 22, 2022
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Analyst Sees This 'Specialty Pharma' Stock Stuck Until Prescription Trends Improve
August 08, 2022
Via
Benzinga
Recap: Collegium Pharmaceutical Q1 Earnings
May 10, 2022
Collegium Pharmaceutical (NASDAQ:COLL) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Collegium Reports Third Quarter 2022 Financial Results
November 03, 2022
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Collegium to Report Third Quarter 2022 Financial Results on November 3, 2022
October 20, 2022
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2022
August 08, 2022
Via
Benzinga
Why Collegium Pharmaceutical's Shares Are Trading Higher Today
April 05, 2022
Via
Benzinga
7 Micro-Cap Stocks to Take a Chance on Now
June 04, 2022
Despite (or because of) their size, some micro-cap stocks, have good value and are overlooked and should be considered by investors.
Via
InvestorPlace
A Preview Of Collegium Pharmaceutical's Earnings
May 09, 2022
Collegium Pharmaceutical (NASDAQ:COLL) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
5 Value Stocks To Watch In The Healthcare Sector
May 09, 2022
What Defines a Value Stock?
Via
Benzinga
5 Value Stocks To Watch In The Healthcare Sector
May 02, 2022
What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E...
Via
Benzinga
Analyst Ratings For Collegium Pharmaceutical
April 06, 2022
Over the past 3 months, 4 analysts have published their opinion on Collegium Pharmaceutical (NASDAQ:COLL) stock. These analysts are typically employed by large Wall Street banks and tasked with...
Via
Benzinga
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
February 24, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Appoints COO David Hering As Interim CEO Adagio Therapeutics, Inc., (...
Via
Benzinga
10 Biggest Price Target Changes For Tuesday
February 15, 2022
JP Morgan raised Ralph Lauren Corporation (NYSE: RL) price target from $137 to $142. Ralph Lauren shares rose 1.2% to $124.00 in pre-market trading.
Via
Benzinga
BDSI Stock Alert: The Deal Sending Little-Known BioDelivery Skyrocketing Today
February 14, 2022
Today, a big takeover announcement has sent shares of BioDelivery and BDSI stock soaring more than 50% on investor enthusiasm for this deal.
Via
InvestorPlace
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front...
Via
Benzinga
32 Stocks Moving In Monday's Mid-Day Session
February 14, 2022
Gainers BioDelivery Sciences International, Inc. (NASDAQ: BDSI) shares jumped 51.9% to $5.53. Collegium Pharmaceutical will acquire BioDelivery Sciences International at $5.60...
Via
Benzinga
52 Biggest Movers From Yesterday
February 15, 2022
Gainers BioDelivery Sciences International, Inc. (NASDAQ: BDSI) shares climbed 52.8% to close at $5.56 on Monday. Collegium Pharmaceutical will acquire BioDelivery Sciences...
Via
Benzinga
Collegium Pharma Broadens Its Pain Portfolio With $600M BioDelivery Sciences Deal
February 14, 2022
Collegium Pharmaceutical Inc (NASDAQ: COLL) will acquire BioDelivery Sciences International Inc (NASDAQ: BDSI) at $5.60 per share in an all-cash transaction,...
Via
Benzinga
A Look Into Healthcare Sector Value Stocks
February 07, 2022
What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E...
Via
Benzinga
5 Value Stocks To Watch In The Healthcare Sector
January 03, 2022
What Defines a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...
Via
Benzinga
Collegium Pharmaceutical, inc (COLL) Q3 2021 Earnings Call Transcript
November 05, 2021
COLL earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
November 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &...
Via
Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...
Via
Benzinga
5 Value Stocks To Watch In The Healthcare Sector
October 11, 2021
The Meaning Behind Value Stocks A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may...
Via
Benzinga
5 Value Stocks To Watch In The Healthcare Sector
August 30, 2021
What are Value Stocks? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...
Via
Benzinga
60 Biggest Movers From Yesterday
August 17, 2021
Gainers NanoVibronix, Inc. (NASDAQ: NAOV) shares jumped 33.7% to close at $3.37 on Monday after the company announced plan to expand product portfolio with introduction of...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.